Clarithromycin / Rifampicin Capsule

This fixed-dose combination leverages the potent synergy between clarithromycin and rifampicin, utilizing dual mechanisms of protein and RNA synthesis inhibition to provide a multi-targeted approach against recalcitrant mycobacterial and staphylococcal infections. By integrating these complementary antimicrobial agents, the formulation broadens the therapeutic spectrum and significantly mitigates the risk of emerging bacterial resistance during long-term treatment. The capsule delivery system ensures precise dosing and optimized bioavailability, providing a stable oral vehicle that facilitates consistent systemic absorption and enhances patient adherence to complex anti-infective protocols.